Journal
BIOCHEMISTRY
Volume 48, Issue 31, Pages 7525-7532Publisher
AMER CHEMICAL SOC
DOI: 10.1021/bi900332f
Keywords
-
Categories
Funding
- National Institutes of Health [AI070544]
- Juvenile Diabetes Research Foundation [1-2005-342]
- Arthritis National Research Foundation (ANRF)
- National Institutes of Health Predoctoral Training [GM067587]
- Biochemical and Molecular Biology at the University of Southern California
- Sardinian government
Ask authors/readers for more resources
The lymphoid tyrosine phosphatase LYP, encoded by the PTPN22 gene, recently emerged as a major player and candidate drug target for human autoimmunity. The enzyme includes a classical N-terminal protein tyrosine phosphatase catalytic domain and a C-terminal PEST-enriched domain, separated by an similar to 300-amino acid interdomain. Little is known about the regulation of LYP. Herein, by analysis of serial truncation mutants of LYP, we show that the phosphatase activity is strongly inhibited by protein regions C-terminal to the catalytic domain. We mapped the minimal inhibitory region to the proximal portion of the interdomain. We show that the activity of LYP is inhibited by an intramolecular mechanism, whereby the proximal portion of the interdomain directly interacts with the catalytic domain and reduces its activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available